PAA Share Price

Open 0.05 Change Price %
High 0.05 1 Day 0.00 0.00
Low 0.05 1 Week 0.00 0.00
Close 0.05 1 Month 0.00 0.00
Volume 401067 1 Year -0.02 -28.57
52 Week High 0.17
52 Week Low 0.05
PAA Important Levels
Resistance 2 0.05
Resistance 1 0.05
Pivot 0.05
Support 1 0.05
Support 2 0.05
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
AKK 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IMU 0.02 100.00%
IMU 0.02 100.00%
PMQ 0.03 50.00%
ARD 0.03 50.00%
ARD 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
EXG 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
SRX 16.00 -37.23%
SRX 16.00 -37.23%
More..

Pharmaust Ltd (ASX: PAA)

PAA Technical Analysis 4
As on 9th Dec 2016 PAA Share Price closed @ 0.05 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.09 & Strong Sell for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
PAA Target for December
1st Target up-side 0.07
2nd Target up-side 0.08
3rd Target up-side 0.09
1st Target down-side 0.03
2nd Target down-side 0.02
3rd Target down-side 0.01
PAA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.pharmaust.com
PAA Address
PAA
29 The Avenue
Suite 7
Nedlands, WA 6009
Australia
Phone: 61 8 9386 4787
Fax: 61 8 9389 1464
PAA Latest News
Interactive Technical Analysis Chart Pharmaust Ltd ( PAA ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pharmaust Ltd
PAA Business Profile
PharmAust Limited, through its subsidiaries, provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries in Australia and internationally. The company operates through Corporate, Exploration, and Pharmaceutical segments. It offers a range of pharmaceutical impurities, degradants, and metabolites of active ingredients and excipients primarily for OTC and generic drugs. The company is also involved in the custom synthesis of analogue libraries, scaffolds, and intermediates; contract drug discovery activities; and development of therapeutic cancer products. In addition, it engages in the exploration of tenements for minerals, and oil and gas. The company holds 80% downstream interests in the Luke River project, a precious and base metal exploration project located in northeast Macedonia. PharmAust Limited is based in Nedlands, Australia.